EPFL researchers have developed an implantable neural chip that tracks communication across brain regions, identifying cognitive and emotional states in real time.

Traditional health-insurance reserving relies on stable historical averages, which break down when a disease spreads rapidly through a population. Researchers from China and the United States have developed a framework that tracks how long each policyholder has been infected, or their "infection age", and links this to the escalating medical costs of disease progression. The approach lets insurers feed real-time outbreak indicators, such as the reproduction number, directly into reserve estimates and stress tests.

What if we could use a cancer’s own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what researchers at the RIKEN Pioneering Research Institute (PRI) in Japan have done. The proof-of-concept study describes how a synthetically designed compound uses the excess carbon monoxide produced in tumor cells to trigger the production of anti-cancer drugs within the cells themselves. Treatment methods based on this technique would be ideal as it selectively targets tumors and avoids harming healthy cells.